IOVA
IOVA
NASDAQ · Biotechnology

Iovance Biotherapeutics Inc

$4.38
-0.06 (-1.35%)
As of Jun 24, 2:06 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target +1,150.5% upside
Low Target $41.45
Average Target $54.77
High Target $77.23
Current Price $4.38
Current
$4.38
Target
$54.77
$41.45 $54.77 avg $77.23
Scenario Analysis
Bear Case
$41.45
846.3%
Low target
Base Case
$54.77
+1,150.5%
Avg target
Bull Case
$77.23
+1,663.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$5.63
-22.2% from high
52-Week Low
$1.66
+163.9% from low
Target vs 52W High
$54.77
+872.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +188.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -8.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.9%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.4%